Investment type
Equity / Common Stock
Latest Disclosed Ownership
1.19M shares
Security Ownership
4%

Mark N. Tompkins ownership in Lomond Therapeutics Holdings, Inc. Common Stock

2025-02-14 - Mark N. Tompkins has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.19M shares of Lomond Therapeutics Holdings, Inc. Common Stock. This represents 4% percent ownership of the company.